Italy· 050190038
GLICLAZIDE TECNIGEN
A gliclazide product containing gliclazide, registered in Italy by TECNIGEN S.R.L., on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Gliclazide is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BB09 (gliclazide), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 7 of them publish a price we can compare per daily dose
Gliclazide · ATC A10BB09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of gliclazide costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.11 in France to $0.61 in Switzerland — a ×5.5 gap.
- Italy: $0.26 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Gliclazide · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.61
- IT Italy$0.26
- FR France$0.11
The record
At a glance
AIFA (Italy)- Active substance
- Gliclazide
- Manufacturer
- TECNIGEN S.R.L.
- Country
- Italy (IT)
- ATC code
- A10BB09
- ATC class
- Gliclazide
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic050190038"60 MG COMPRESSE A RILASCIO PROLUNGATO" 30 COMPRESSE IN BLISTER PVDC/PVC/ALEUR 5.37
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for gliclazide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gliclazide · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Gliclazide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDIAPREL MRLes Laboratoires Servier, Suresnes cedex
- PolandClaziconSynoptis Pharma Sp. z o.o.
- FranceDIAMICRON 60 mg, comprimé sécable à libération modifiéeLES LABORATOIRES SERVIER
- SpainDIAMICRON 60 mg COMPRIMIDOS DE LIBERACION MODIFICADALes Laboratoires Servier
- United KingdomBilxona 60mg modified-release tabletsActavis UK Ltd
- CanadaAG-GLICLAZIDE MRANGITA PHARMA INC.
- NetherlandsDIAMICRON MR 60 mg, tabletten met gereguleerde afgifteLes Laboratoires Servier
- BelgiumGliclazide Lupin 60 mgLupin (Europe)
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Diamicron Mr, Gliclada
- Belgium · Gliclazide Sandoz, Uni Diamicron
- Bulgaria · Гликлада, Диаб
- Cyprus · Diamicron, Glicron
- Czechia · Diaprel Mr, Gliclazid Viatris
- Germany · Diamicron Uno, Glibemat
- Denmark · Diamicron Uno, Gliclazid Krka
- Estonia · Diaprel, Diaprel Mr
- Spain · Diamicron, Gliclazida Aurovitas
- France · Diamicron, Diamicron 60 Mg
- United Kingdom (Northern Ireland) · Dacadis Mr, Diamicron
- Greece · Diamicron, Diamicron Mr
- Croatia · Diaprel Mr, Gliclada
- Hungary · Diaprel Mr, Gliclada
- Ireland · Diaclide Mr, Diacronal Mr
- Iceland · Diamicron Uno, Gliclatim
- Lithuania · Diaprel Mr, Gliclada
- Luxembourg · Diamicron, Uni Gliclazide Eg
- Latvia · Diaprel Mr, Gliclada
- Malta · Diamicron, Gliclazide Bp Accord Healthcare
- Netherlands · Diamicron Mr, Gliclazide Aurobindo
- Poland · Clazicon, Diabrezide
- Portugal · Diamicron Lm, Gliclazida Alter
- Romania · Diaprel Mr, Gliclazide Gemax Pharma
- Slovenia · Diaprel, Diaprel Mr
- Slovakia · Diaprel Mr, Gliclada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7f001f1-6166-40ca-bc23-642a62c4ea85 GET /v1/drugs/f7f001f1-6166-40ca-bc23-642a62c4ea85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"60 MG COMPRESSE A RILASCIO PROLUNGATO\" 30 COMPRESSE IN BLISTER PVDC/PVC/AL",
"source": "aifa",
"currency": "EUR",
"substance": "Gliclazide",
"reference_pack": "30 UNITA' 60 MG - USO ORALE (RILASCIO MODIFICATO)",
"public_price_eur": 5.37,
"ssn_reference_price_eur": 5.37
}See everything about gliclazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.